We used mass spectrometry to monitor cAMP-dependent protein kinase catalyse
d phosphorylation of human cardiac troponin I in vitro. Phosphorylation of
isolated troponin I by cAMP-dependent protein kinase resulted in the covale
nt incorporation of phosphate on at least five different sites on troponin
I, and a S22/23A troponin I mutant incorporated phosphates on at least thre
e sites. In addition to the established phosphorylation sites (S22 and S23)
we found that S38 and S165 were the other two main sites of phosphorylatio
n. These 'overphosphorylation' sites were not phosphorylated sufficiently s
lower than S22 and S23 that we could isolate pure S22/23 bisphosphorylated
troponin I. Overphosphorylation of troponin I reduced its affinity for trop
onin C, as measured by isothermal titration microcalorimetry. Phosphorylati
on of S22/23A also decreased its affinity for troponin C indicating that ph
osphorylation of S38 and/or S165 impedes binding of troponin I to troponin
C. Formation of a troponin I/troponin C complex prior to cAMP-dependent pro
tein kinase treatment did not prevent overphosphorylation. When whole tropo
nin was phosphorylated by cAMP-dependent protein kinase, however, [P-32]pho
sphate was incorporated only into troponin I and only at S22 and S23. Mass
spectrometry confirmed that overphosphorylation is abolished in the ternary
complex. Troponin I bisphosphorylated exclusively at S22 and S23 troponin
I showed reduced affinity for troponin C but the effect was diminished with
respect to overphosphorylated troponin I. These results show that care sho
uld be exercised when interpreting data obtained with troponin I phosphoryl
ated in vitro.